These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 3978880)

  • 21. Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
    Hoyer PF; Brodeh J
    J Am Soc Nephrol; 2006 Apr; 17(4):1151-7. PubMed ID: 16540560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic-pituitary-adrenal (HPA) function in adrenocortical steroid treated minimal change nephrotic syndrome.
    Moel DI; Kwun YA; Teitcher J
    Clin Nephrol; 1980 Jul; 14(1):36-41. PubMed ID: 6250751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steroid-sensitive nephrotic syndrome: from childhood to adulthood.
    Fakhouri F; Bocquet N; Taupin P; Presne C; Gagnadoux MF; Landais P; Lesavre P; Chauveau D; Knebelmann B; Broyer M; Grünfeld JP; Niaudet P
    Am J Kidney Dis; 2003 Mar; 41(3):550-7. PubMed ID: 12612977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG; Gallo G; Zumino D; Díaz MA; Vitacco M
    Bol Med Hosp Infant Mex; 1981; 38(3):457-72. PubMed ID: 7271977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome.
    Warshaw BL; Hymes LC
    Pediatrics; 1989 May; 83(5):694-9. PubMed ID: 2717285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of relapse in steroid-sensitive nephrotic syndrome.
    Noer MS
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1313-20. PubMed ID: 16438164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
    Mahmoud I; Basuni F; Sabry A; El-Husseini A; Hassan N; Ahmad NS; Elbaz M; Moustafa F; Sobh M
    Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic nephrotic syndrome with minimal glomerular lesions in children (author's transl)].
    Scharer K; Gilli G
    Ateneo Parmense Acta Biomed; 1975; 46(5):455-71. PubMed ID: 1232998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
    Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
    Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesangial proliferative glomerulonephritis in children.
    Uszycka-Karcz M; Stolarczyk J; Wrzolkowa T; Kamińska H; Zurowska A; Marczak E; Schramm K; Mierzewski P
    Int J Pediatr Nephrol; 1982 Dec; 3(4):251-6. PubMed ID: 7166451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
    Goszczyk A; Jung A; Bochniewska V; Straz-Zebrowska E
    Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():25-6. PubMed ID: 11081338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remissions and relapses in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Altieri P; Locatelli F; Pappalettera M
    Nephrol Dial Transplant; 1992; 7 Suppl 1():85-90. PubMed ID: 1337188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pefloxacin in steroid dependent and resistant idiopathic nephrotic syndrome.
    Sharma RK; Sahu KM; Gulati S; Gupta A
    J Nephrol; 2000; 13(4):271-4. PubMed ID: 10946806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
    Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Longitudinal study in children with the nephrotic syndrome and minimal glomerular lesion].
    Martini RJ; Gomila A; Solanas G
    Bol Med Hosp Infant Mex; 1977; 34(5):1105-16. PubMed ID: 758027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ifosfamide in the treatment of nephrotic syndrome (author's transl)].
    Gekle D; Daigeler C
    Klin Padiatr; 1977 Sep; 189(5):370-5. PubMed ID: 562447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
    Cade R; Mars D; Privette M; Thompson R; Croker B; Peterson J; Campbell K
    Arch Intern Med; 1986 Apr; 146(4):737-41. PubMed ID: 3963956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A; Polito C; Del Gado R; Foglia AC
    Child Nephrol Urol; 1988-1989; 9(4):200-2. PubMed ID: 3255483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.